KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Assets Average (2016 - 2026)

Biogen has reported Assets Average over the past 18 years, most recently at $29.5 billion for Q1 2026.

  • For Q1 2026, Assets Average rose 5.06% year-over-year to $29.5 billion; the TTM value through Mar 2026 reached $29.5 billion, up 5.06%, while the annual FY2025 figure was $28.7 billion, 4.73% up from the prior year.
  • Assets Average for Q1 2026 was $29.5 billion at Biogen, roughly flat from $29.3 billion in the prior quarter.
  • Over five years, Assets Average peaked at $29.5 billion in Q1 2026 and troughed at $23.7 billion in Q1 2022.
  • A 5-year average of $26.7 billion and a median of $26.7 billion in 2024 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: decreased 2.03% in 2022 and later rose 11.39% in 2023.
  • Year by year, Assets Average stood at $24.7 billion in 2022, then increased by 11.39% to $27.5 billion in 2023, then rose by 2.41% to $28.2 billion in 2024, then grew by 4.05% to $29.3 billion in 2025, then rose by 0.47% to $29.5 billion in 2026.
  • Business Quant data shows Assets Average for BIIB at $29.5 billion in Q1 2026, $29.3 billion in Q4 2025, and $28.8 billion in Q3 2025.